Respiratory Failure: A Definition and Classification Proposal
DOI:
https://doi.org/10.24950/rspmi.1359Keywords:
Respiratory Distress Syndrome/classification, Respiratory Insufficiency/classificationAbstract
At present, respiratory failure (RF) is commonly defined as a laboratory abnormality, evident only after performing arterial blood gas analysis (ABG), instead of being recognized as a clinical syndrome with characteristic symptoms and signs, different stages and severity levels, and with aetiology dependent physiopathological features. This often complica its clinical diagnosis, especially in early stages, hampers its study and understanding and prevents appropriate treatment to be given in due time, in numerous situations. Furthermore, it hinders clinical research for a better understanding of the syndrome and its treatment, in different homogeneous groups of patients with RF. Clinical practice demonstrates that we have an incomplete knowledge of RF, its diagnostic approach, management and treatment. RF directly impacts patient’s quality of life and prognosis. It should be considered a nosologic entity, with unique clinical, physiopathological and dynamic characteristics, that demands a dedicated investigation aiming to be better understood and treated with the goal of changing its course and improve clinical outcomes.
Downloads
References
Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J. 2003; 22:3s14s.
Eui-Sik S, Hart N. Respiratory failure. Medicine. 2012;40: 293-7.
Scala R, Heunks L. Highlights in acute respiratory failure. Eur Respir Rev. 2018;27:180008. doi: 10.1183/16000617.0008-2018.
Luhr OR, Antonsen K, Karlsson M, Aardal S, Thorsteinsson A, Frostell CG, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland: The ARF Study Group. Am J Respir Crit Care Med. 1999; 159: 1849-61. doi: 10.1164/ajrccm.159.6.9808136.
Vincent JL, Akça S, De Mendonça A, Haji-Michael P, Sprung C, Moreno R, et al. The epidemiology of acute respiratory failure in critically ill patients(*). Chest. 2002;121:1602-9. doi: 10.1378/chest.121.5.1602.
Pham T, Pesenti A, Bellani G, et al. Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study. Eur Respir J. 2021; 57: 2003317 doi: 10.1183/13993003.03317-2020].
Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med. 2003;168:1438-44. doi: 10.1164/ rccm.200301-072OC.
Lemiale V, Mokart D, Resche-Rigon M, Pène F, Mayaux J, Faucher E, et al. Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial. JAMA. 2015;314:1711-9. doi: 10.1001/ jama.2015.12402.
Ranieri VM, Tonetti T, Navalesi P, Nava S, Antonelli M, Pesenti A, et al. High-Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in Patients with COVID-19. Am J Respir Crit Care Med. 2022;205:431-9. doi: 10.1164/rccm.202109-2163OC.
Villar J, Schultz MJ, Kacmarek RM. The LUNG SAFE: a biased presentation of the prevalence of ARDS! Crit Care. 2016;20:108. doi: 10.1186/s13054- 016-1273-x.
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315:788-800. doi: 10.1001/jama.2016.0291. Erratum in: JAMA. 2016;316:350. Erratum in: JAMA. 2016;316:350.
Laffey JG, Madotto F, Bellani G, Pham T, Fan E, Brochard L, et al. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study. Lancet Respir Med. 2017;5:627-38. doi: 10.1016/S2213-2600(17)30213-8.
Elshof J, Duiverman ML, Wijkstra PJ. The NIVO score: can it help to improve noninvasive ventilation in daily clinical practice? Eur Respir J. 2021;58:2100336. doi: 10.1183/13993003.00336-2021.
Javaheri S, Sicilian L. Lung function, breathing pattern, and gas exchange in interstitial lung disease. Thorax. 1992;47:93-7. doi: 10.1136/thx.47.2.93.
Bag R, Suleman N, Guntupalli KK. Respiratory failure in interstitial lung disease. Curr Opin Pulm Med. 2004;10:412-8. doi: 10.1097/01. mcp.0000136404.09581.41.
Hook JL, Arcasoy SM, Zemmel D, Bartels MN, Kawut SM, Lederer DJ. Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis. Eur Respir J. 2012 ;39:359-65. doi: 10.1183/09031936.00108111.
Gläser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med. 2009;103:317-24. do 10.1016/j.rmed.2008.08.005.
Decramer M. Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation. Eur Respir J Suppl. 2003;47:47s-56s. doi: 10.1183/09031936.03.00009903.
Budweiser S, Jörres RA, Pfeifer M. Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:605-18. doi: 10.2147/copd. s3814.
Boutou AK, Tanner RJ, Lord VM, Hogg L, Nolan J, Jefford H, et al. An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD. BMJ Open Respir Res. 2014;1:e000051. doi: 10.1136/bmjresp-2014-000051.
ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13-64. doi: 10.1164/rccm.201309-1634ST. Erratum in: Am J Respir Crit Care Med. 2014;189:1570.
Swenson KE, Ruoss SJ, Swenson ER. The Pathophysiology and Dangers of Silent Hypoxemia in COVID-19 Lung Injury. Ann Am Thorac Soc. 2021;18:1098-105. doi: 10.1513/AnnalsATS.202011-1376CME.
Kallet R, Branson RD, Lipnick MS; Respiratory drive, dyspnea and silent hypoxemia: a physiological review in the context of Coronavirus Disease 19. Respir Care 2022; 10.4187/respcare. 10075 doi:10.4187/respcare.10075.
Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435-52. doi: 10.1164/rccm.201111-2042ST.
Gravelyn TR, Weg JG. Respiratory rate as an indicator of acute respiratory dysfunction. JAMA. 1980;244:1123-5.
Centre for Clinical Practice at NICE (UK). Acutely ill patients in hospital: recognition of and response to acute illness in adults in hospital. London: National Institute for Health and Clinical Excellence (UK); 2007.
Hall JE. Guyton and Hall’s textbook of medical physiology. 13th ed. Amsterdam: Elsevier Inc.; 2016.
Royal College of Physicians. National Early Warning Score (NEWS) 2. Standardising the Assessment of Acute-illness Severity in the NHS. [accessed June 2022] Available at: https://www.rcplondon.ac.uk/file/8636/ download?token=lOf4KLST.
Neff TA. Routine oximetry. A fifth vital sign? Chest. 1988;94:227. doi: 10.1378/chest.94.2.227a.
Chan ED, Chan MM, Chan MM. Pulse oximetry: understanding its basic principles facilitates appreciation of its limitations. Respir Med. 2013;107:789-99. doi: 10.1016/j.rmed.2013.02.004.
Jubran A. Pulse oximetry. Crit Care. 2015;19:272. doi: 10.1186/s13054- 015-0984-8.
Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial Bias in Pulse Oximetry Measurement [published correction appears in N Engl J Med. 2021;385: 2496]. N Engl J Med 2020; 383: 2477-8.
Sowho M, Amatoury J, Kirkness JP, Patil SP. Sleep and respiratory physiology in adults. Clin Chest Med. 2014;35:469-81. doi: 10.1016/j. ccm.2014.06.002.
Faverio P, De Giacomi F, Bonaiti G, Stainer A, Sardella L, Pellegrino G, et al. Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights. Int J Med Sci. 2019;16:967-80. doi: 10.7150/ijms.32752.
Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1428-46. doi: 10.1183/09031936.00150314.
Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1447-78. doi: 10.1183/09031936.00150414.
Gupta R, Ruppel GL, Espiritu JR. Exercise-Induced Oxygen Desaturation during the 6-Minute Walk Test. Med Sci. 2020;8:8. doi: 10.3390/medsci8010008.
Berry RB, Quan SF, Abreu AR, ; for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.6. Darien: American Academy of Sleep Medicine; 2020.
Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146:1387-94. doi: 10.1378/chest.14- 0970.
Böing S, Randerath WJ. Chronic hypoventilation syndromes and sleep-related hypoventilation. J Thorac Dis. 2015;7:1273-85. doi: 10.3978/j. issn.2072-1439.2015.06.10.
Simonds AK. Chronic hypoventilation and its management. Eur Respir Rev. 2013;22:325-32. doi: 10.1183/09059180.00003113.
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012; 307: doi:10.1001/jama.2012.5669.
Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017; 50: 1602426. doi: 10.1183/13993003.02426-2016.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
